| Market Research A to Z | Company Profiles A to Z | Register | Contact Us |
| +44 (0) 203 086 8600 Call us on |
DNA Microarray 2012: A Focus on Sales Growth
Market |
Healthcare and Medical |
Report Type |
Market Research |
Country |
Global |
Published |
15 September 2012 |
Number of Pages |
149 |
1-3 hours, 24 hour max |
|
Publisher |
Biopharm Reports |
File Format |
Global DNA microarray market to hit value of $3 billion by 2015
From the early use of miniaturised microarrays for the analysis of gene expression in the mid 1990s, this technique has established markets that are expected to reach $3 billion by 2015. However markets are also changing as new applications are developed and new instruments and competitive technologies such as PCR, are launched. Today, more than ever, developers and vendors in the microarray field are targeting their resources in those areas that best support their own sales and growth strategies.
Report Scope
This report, based on an analysis of prevailing and emerging market conditions in the DNA microarray field, has been produced to assist marketing and sales, and the identification of new opportunities. It is the outcome of an extensive global study involving more than 200 experienced DNA microarray users. It's findings provide a "focus on sales growth" to developers and vendors in the microarray field, and the changes that are driving these developments.
Analysis
As part of this report, market areas outlined below have been analysed to provide information relevant to marketing and sales, new market opportunities, qualified sales leads, customer needs and future plans, competitive position, new and emerging applications, growing and declining areas and threats.
Market Areas
- Routine use: Use of DNA microarrays by end-users for running routine (developed and validated) microarray tests, the development or validation of microarray tests and for the qualitative discovery using microarray methods
- Suppliers: Purchases of DNA microarrays and related systems by end-users from more than 30 companies and anticipated DNA microarray purchases by end-users from more than 30 companies over the next three years, each ranked according to their competitive position.
- Methods: Current use of more than 15 DNA microarray methods by end-users and the anticipated use of these methods by end-users over the next three years, each ranked according to their competitive position.
- Applications: Current use of more than 20 DNA microarray applications by end-users and the anticipated use of these applications by end-users over the next three years, each ranked according to their competitive position.
- Preferred Companies: End-users' preferred companies in the DNA microarray field, each ranked according to their competitive position.
- Products: End-users' preferred products (and associated companies) in the DNA microarray field, each ranked according to their competitive position.
- Strengths: End-users' disclosures of the strengths of their preferred products in the DNA microarray field, each ranked according to their competitive position.
- Weaknesses: End-users' disclosures of the weaknesses of their preferred products in the DNA microarray field, each ranked according to their relative position.
- Financial Budgets: End-users' annual financial budgets for DNA microarray studies.
- Budget Breakdown: The breakdown of end-users' DNA microarray financial budgets in eight key areas, relating to their current expenditure on DNA microarray products and activities.
- Future Budget Breakdown: The breakdown of end-users' microarray financial budgets in eight key areas, relating to their anticipated expenditure over the next three years, on DNA microarray products and activities.
- Future Budgets: End-users' anticipated changes (percentage increases or decrease) over the next three years, relating to their DNA microarray activities
- Consumables: End-users' top three consumables, associated with their DNA microarray activities.
- Quality Control: End-users' adherence to established quality control guidelines or procedures (e.g. MAIME), relating to the conduct of DNA microarray studies.
- Challenges: End-users' disclosures on molecular types that present the greatest technical challenges to DNA microarray analysis, together with the associated sample types (matrices), associated microarray methods and underlying reasons.
- Innovation: End-users' current needs relating to 12 key areas of required innovation in the DNA microarray field, each ranked (on a scale of 1 to 10) according to their importance.
- Recent Innovations: End-users disclosures on the most important innovations relating to their use of DNA microarrays, over the last three years.
- Future Innovation: End-users' disclosures on what they anticipate will be the most important innovations in the DNA microarray field, over the next three years.
- Biomarkers: End-users' application of DNA microarray methods for the study of disease biomarkers, including molecular types and their clinical utilities.
- Organisations: End-users organisations include clinics or hospitals, government bodies, large international companies, research institutes, small and medium sized companies, universities and veterinary centres.
- Fields: End-users underlying fields include biotechnology, chemicals, clinical or hospital, defence, energy, environmental, food and drink, forensics, geology, government, healthcare, natural products, pharmaceuticals, research institutes, security and universities.
- Bioinformatics Software: End-users' disclosures on their preferred bioinformatics software, associated with DNA microarray studies.
- Purpose: End-users' underlying reasons for using DNA microarray analysis across 13 major fields (biotechnology, chemicals, clinical or hospital, defence, energy, environmental, food and drink, forensics, geology, government, healthcare, natural products, pharmaceuticals, research institutes, security, university), each ranked according to their relative importance.
- Samples: Study sample types analysed by end-users using DNA microarray methods, each ranked according to their relative importance.
- Sample Preparation: The use of sample preparation methods by end-users for DNA microarray studies, each ranked according to their importance.
Visitor Comments
|
All posts are pre-moderated and must obey the house rules. |
|
Healthcare and Medical Company Profiles
Find latest Healthcare and Medical Company Profiles with up to date financial, strategic, operational, SWOT analysis and product information for the leading healthcare and medical companies.
Competitor Tracking
Do you need to track your competitors and customers on a continuous basis? We have the expertise to provide you with a cost-effective, fully customised competitor tracking portal, which collates data on your competitors on a continuous basis. Contact us for a free consultation and demonstration.
Become an Affiliate
Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?
Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website.
Custom Research
Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.
